Healthcare -
Biotechnology - NASDAQ - US
$ 21.98
-1.7 %
$ 16.2 B
Market Cap
-95.57
P/E
SMMT - TOTAL LIABILITIES
Total Liabilities SMMT - Summit Therapeutics Inc.
125 M
LAST VALUE
104.03%
2 YEAR CAGR
40.85%
5 YEAR CAGR
44.84%
10 YEAR CAGR